Company / Current Assets
Imunon, Inc. Current Assets History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$18.2M
FY2023
5-year range
$16.2M / $51.9M
FY2019-FY2023
Trend
-50.9%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 7 years, ranging from $16M in FY2019 to $52M in FY2021.
Based on SEC 10-K filings.
$18M in FY2023 with a 5-year CAGR of -8.3%.
Declined from $52M to $18M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- -8.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -8.3%, indicating a declining trend.
- In FY2023, current assets decreased 50.9% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $18.2M | -50.9% |
| FY2022 | $37.2M | -28.5% |
| FY2021 | $51.9M | +175.9% |
| FY2020 | $18.8M | +16.0% |
| FY2019 | $16.2M | -42.3% |
| FY2018 | $28.1M | +38.7% |
| FY2015 | $20.3M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026